Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains.

Steimle A, Menz S, Bender A, Ball B, Weber ANR, Hagemann T, Lange A, Maerz JK, Parusel R, Michaelis L, Schäfer A, Yao H, Löw HC, Beier S, Tesfazgi Mebrhatu M, Gronbach K, Wagner S, Voehringer D, Schaller M, Fehrenbacher B, Autenrieth IB, Oelschlaeger TA, Frick JS.

PLoS Biol. 2019 Jun 17;17(6):e3000334. doi: 10.1371/journal.pbio.3000334. [Epub ahead of print]

2.

Potential of marine natural products against drug-resistant bacterial infections.

Liu M, El-Hossary EM, Oelschlaeger TA, Donia MS, Quinn RJ, Abdelmohsen UR.

Lancet Infect Dis. 2019 Apr 25. pii: S1473-3099(18)30711-4. doi: 10.1016/S1473-3099(18)30711-4. [Epub ahead of print] Review.

PMID:
31031171
3.

A New Bioactive Compound From the Marine Sponge-Derived Streptomyces sp. SBT348 Inhibits Staphylococcal Growth and Biofilm Formation.

Balasubramanian S, Skaf J, Holzgrabe U, Bharti R, Förstner KU, Ziebuhr W, Humeida UH, Abdelmohsen UR, Oelschlaeger TA.

Front Microbiol. 2018 Jul 11;9:1473. doi: 10.3389/fmicb.2018.01473. eCollection 2018.

4.

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ.

Bury S, Soundararajan M, Bharti R, von Bünau R, Förstner KU, Oelschlaeger TA.

Front Microbiol. 2018 May 29;9:929. doi: 10.3389/fmicb.2018.00929. eCollection 2018.

5.

An adherent mucus layer attenuates the genotoxic effect of colibactin.

Reuter C, Alzheimer M, Walles H, Oelschlaeger TA.

Cell Microbiol. 2018 Feb;20(2). doi: 10.1111/cmi.12812. Epub 2017 Dec 5.

PMID:
29156489
6.

Improving anti-trypanosomal activity of alkamides isolated from Achillea fragrantissima.

Skaf J, Hamarsheh O, Berninger M, Balasubramanian S, Oelschlaeger TA, Holzgrabe U.

Fitoterapia. 2018 Mar;125:191-198. doi: 10.1016/j.fitote.2017.11.001. Epub 2017 Nov 3.

PMID:
29108932
7.

Inhibitory potential of strepthonium A against Shiga toxin production in enterohemorrhagic Escherichia coli (EHEC) strain EDL933.

Cheng C, Balasubramanian S, Fekete A, Krischke M, Mueller MJ, Hentschel U, Oelschlaeger TA, Abdelmohsen UR.

Nat Prod Res. 2017 Dec;31(23):2818-2823. doi: 10.1080/14786419.2017.1297443. Epub 2017 Mar 13.

PMID:
28287277
8.

Marine Sponge-Derived Streptomyces sp. SBT343 Extract Inhibits Staphylococcal Biofilm Formation.

Balasubramanian S, Othman EM, Kampik D, Stopper H, Hentschel U, Ziebuhr W, Oelschlaeger TA, Abdelmohsen UR.

Front Microbiol. 2017 Feb 16;8:236. doi: 10.3389/fmicb.2017.00236. eCollection 2017.

9.

Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections.

Abdelmohsen UR, Balasubramanian S, Oelschlaeger TA, Grkovic T, Pham NB, Quinn RJ, Hentschel U.

Lancet Infect Dis. 2017 Feb;17(2):e30-e41. doi: 10.1016/S1473-3099(16)30323-1. Epub 2016 Dec 13. Review.

PMID:
27979695
10.

Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB).

Firdessa R, Good L, Amstalden MC, Chindera K, Kamaruzzaman NF, Schultheis M, Röger B, Hecht N, Oelschlaeger TA, Meinel L, Lühmann T, Moll H.

PLoS Negl Trop Dis. 2015 Oct 2;9(10):e0004041. doi: 10.1371/journal.pntd.0004041. eCollection 2015.

11.

Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: relevance for drug delivery systems.

Firdessa R, Oelschlaeger TA, Moll H.

Eur J Cell Biol. 2014 Aug-Sep;93(8-9):323-37. doi: 10.1016/j.ejcb.2014.08.001. Epub 2014 Aug 23.

PMID:
25224362
12.

Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917.

Reister M, Hoffmeier K, Krezdorn N, Rotter B, Liang C, Rund S, Dandekar T, Sonnenborn U, Oelschlaeger TA.

J Biotechnol. 2014 Oct 10;187:106-7. doi: 10.1016/j.jbiotec.2014.07.442. Epub 2014 Aug 2.

PMID:
25093936
13.

Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Kleta S, Nordhoff M, Tedin K, Wieler LH, Kolenda R, Oswald S, Oelschlaeger TA, Bleiss W, Schierack P.

Infect Immun. 2014 May;82(5):1801-12. doi: 10.1128/IAI.01431-13. Epub 2014 Feb 18.

14.

Metabolic glycoengineering of Staphylococcus aureus reduces its adherence to human T24 bladder carcinoma cells.

Memmel E, Homann A, Oelschlaeger TA, Seibel J.

Chem Commun (Camb). 2013 Aug 25;49(66):7301-3. doi: 10.1039/c3cc43424a.

PMID:
23852343
15.

Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo.

Becker S, Oelschlaeger TA, Wullaert A, Vlantis K, Pasparakis M, Wehkamp J, Stange EF, Gersemann M.

PLoS One. 2013;8(2):e55620. doi: 10.1371/journal.pone.0055620. Epub 2013 Feb 13. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/13f3d7ee-a72c-4879-bedb-8e73b6b364ac. Vlantis, Katerina [added].

16.

Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.

PMID:
23312798
17.

More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus.

Troge A, Scheppach W, Schroeder BO, Rund SA, Heuner K, Wehkamp J, Stange EF, Oelschlaeger TA.

Int J Med Microbiol. 2012 Dec;302(7-8):304-14. doi: 10.1016/j.ijmm.2012.09.004. Epub 2012 Nov 4.

PMID:
23131416
18.

Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.

Seo EJ, Weibel S, Wehkamp J, Oelschlaeger TA.

Int J Med Microbiol. 2012 Nov;302(6):276-87. doi: 10.1016/j.ijmm.2012.05.002. Epub 2012 Jun 28.

PMID:
22748509
19.

Modeling antibiotic and cytotoxic effects of the dimeric isoquinoline IQ-143 on metabolism and its regulation in Staphylococcus aureus, Staphylococcus epidermidis and human cells.

Cecil A, Rikanović C, Ohlsen K, Liang C, Bernhardt J, Oelschlaeger TA, Gulder T, Bringmann G, Holzgrabe U, Unger M, Dandekar T.

Genome Biol. 2011;12(3):R24. doi: 10.1186/gb-2011-12-3-r24. Epub 2011 Mar 21.

20.

E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cells.

Schierack P, Kleta S, Tedin K, Babila JT, Oswald S, Oelschlaeger TA, Hiemann R, Paetzold S, Wieler LH.

PLoS One. 2011 Feb 17;6(2):e14712. doi: 10.1371/journal.pone.0014712.

21.

Bacteria as tumor therapeutics?

Oelschlaeger TA.

Bioeng Bugs. 2010 Mar-Apr;1(2):146-7. doi: 10.4161/bbug.1.2.11248. Epub 2010 Jan 15. No abstract available.

22.

Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility.

Stritzker J, Weibel S, Seubert C, Götz A, Tresch A, van Rooijen N, Oelschlaeger TA, Hill PJ, Gentschev I, Szalay AA.

Int J Med Microbiol. 2010 Nov;300(7):449-56. doi: 10.1016/j.ijmm.2010.02.004. Epub 2010 May 23.

PMID:
20547100
23.

Mechanisms of probiotic actions - A review.

Oelschlaeger TA.

Int J Med Microbiol. 2010 Jan;300(1):57-62. doi: 10.1016/j.ijmm.2009.08.005. Epub 2009 Sep 23. Review.

PMID:
19783474
24.

Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae.

Putze J, Hennequin C, Nougayrède JP, Zhang W, Homburg S, Karch H, Bringer MA, Fayolle C, Carniel E, Rabsch W, Oelschlaeger TA, Oswald E, Forestier C, Hacker J, Dobrindt U.

Infect Immun. 2009 Nov;77(11):4696-703. doi: 10.1128/IAI.00522-09. Epub 2009 Aug 31.

25.

Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.

Remer KA, Bartrow M, Roeger B, Moll H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2009 Nov;299(7):467-78. doi: 10.1016/j.ijmm.2009.03.003. Epub 2009 May 20.

PMID:
19467927
26.

Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.

Bickert T, Trujillo-Vargas CM, Duechs M, Wohlleben G, Polte T, Hansen G, Oelschlaeger TA, Erb KJ.

Int Arch Allergy Immunol. 2009;149(3):219-30. doi: 10.1159/000199717. Epub 2009 Feb 12.

PMID:
19218814
27.

Carbohydrate receptors of bacterial adhesins: implications and reflections.

Ohlsen K, Oelschlaeger TA, Hacker J, Khan AS.

Top Curr Chem. 2009;288:17-65. doi: 10.1007/128_2008_10.

PMID:
22328026
28.

Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.

Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA.

Int J Med Microbiol. 2007 Jun;297(3):151-62. Epub 2007 Apr 19.

PMID:
17448724
29.

Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K.

Infect Immun. 2007 May;75(5):2399-407. Epub 2007 Feb 5.

30.

Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.

Schultz M, Watzl S, Oelschlaeger TA, Rath HC, Göttl C, Lehn N, Schölmerich J, Linde HJ.

J Microbiol Methods. 2005 Jun;61(3):389-98.

PMID:
15767015
31.

Impact of pathogenicity islands in bacterial diagnostics.

Oelschlaeger TA, Hacker J.

APMIS. 2004 Nov-Dec;112(11-12):930-6. Review.

PMID:
15638844
32.

A Salmonella fim homologue in Citrobacter freundii mediates invasion in vitro and crossing of the blood-brain barrier in the rat pup model.

Hess P, Altenhöfer A, Khan AS, Daryab N, Kim KS, Hacker J, Oelschlaeger TA.

Infect Immun. 2004 Sep;72(9):5298-307.

33.

The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.

Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA.

FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):223-9.

34.

The high-pathogenicity island is absent in human pathogens of Salmonella enterica subspecies I but present in isolates of subspecies III and VI.

Oelschlaeger TA, Zhang D, Schubert S, Carniel E, Rabsch W, Karch H, Hacker J.

J Bacteriol. 2003 Feb;185(3):1107-11.

35.

The avian chorioallantoic membrane in ovo--a useful model for bacterial invasion assays.

Adam R, Mussa S, Lindemann D, Oelschlaeger TA, Deadman M, Ferguson DJ, Moxon R, Schroten H.

Int J Med Microbiol. 2002 Sep;292(3-4):267-75.

PMID:
12398217
36.

Analysis of pathogenicity islands of STEC.

Oelschlaeger TA, Dobrindt U, Janke B, Middendorf B, Karch H, Hacker J.

Methods Mol Med. 2003;73:99-112. Review. No abstract available.

PMID:
12375447
37.

Pathogenicity islands of uropathogenic E. coli and the evolution of virulence.

Oelschlaeger TA, Dobrindt U, Hacker J.

Int J Antimicrob Agents. 2002 Jun;19(6):517-21.

PMID:
12135843
38.

Role of fibronectin in curli-mediated internalization.

Gophna U, Oelschlaeger TA, Hacker J, Ron EZ.

FEMS Microbiol Lett. 2002 Jun 18;212(1):55-8.

39.

Virulence factors of uropathogens.

Oelschlaeger TA, Dobrindt U, Hacker J.

Curr Opin Urol. 2002 Jan;12(1):33-8. Review.

PMID:
11753131
40.

Adhesins as invasins.

Oelschlaeger TA.

Int J Med Microbiol. 2001 Apr;291(1):7-14. Review. No abstract available.

PMID:
11403413
41.

Yersinia HPI in septicemic Escherichia coli strains isolated from diverse hosts.

Gophna U, Oelschlaeger TA, Hacker J, Ron EZ.

FEMS Microbiol Lett. 2001 Mar 1;196(1):57-60.

42.

Type 1 pili of Citrobacter freundii mediate invasion into host cells.

Hess P, Daryab N, Michaelis K, Reisenauer A, Oelschlaeger TA.

Adv Exp Med Biol. 2000;485:225-35. No abstract available.

PMID:
11109110
43.

Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae.

Sahly H, Podschun R, Oelschlaeger TA, Greiwe M, Parolis H, Hasty D, Kekow J, Ullmann U, Ofek I, Sela S.

Infect Immun. 2000 Dec;68(12):6744-9.

44.

Receptor structure for F1C fimbriae of uropathogenic Escherichia coli.

Khan AS, Kniep B, Oelschlaeger TA, Van Die I, Korhonen T, Hacker J.

Infect Immun. 2000 Jun;68(6):3541-7.

45.

Microtubule dependent invasion pathways of bacteria.

Oelschlaeger TA, Kopecko DJ.

Subcell Biochem. 2000;33:3-19. Review. No abstract available.

PMID:
10804849
46.

Strategies of bacterial interaction with eukaryotic cells.

Oelschlaeger TA, Hacker J.

Subcell Biochem. 2000;33:xxix-xxxviii. Review. No abstract available.

PMID:
10804848
47.

[Adherence and invasion-two pathogenicity factors in bacterial and fungal pathogens].

Müller FM, Morschhäuser J, Köhler G, Oelschlaeger TA, Ziebuhr W, Hacker J.

Mycoses. 1999;42 Suppl 1:39-42. Review. German.

PMID:
10592714
48.
49.
50.

Uptake pathways of clinical isolates of Proteus mirabilis into human epithelial cell lines.

Oelschlaeger TA, Tall BD.

Microb Pathog. 1996 Jul;21(1):1-16.

PMID:
8827702

Supplemental Content

Loading ...
Support Center